Total Funding
3
14
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
365733
Biofortuna develops a range of molecular diagnostic products using proprietary freeze-dried technology.
- Harry Singh: Commercial Director
- Matthew Kelly: Software Developer/Bioinformatician
About the Company
Biofortuna provides molecular diagnostics services. It manufactures HLA and ABO genotyping product families for the transplantation and haematology markets. The company is also developing antibody screening, genotyping and phenotyping products, software for genotyping applications, transplant monitoring, and platforms for clinical laboratories,
research centers and point-of-care customers. In addition, Biofortuna Ltd. provides genotyping and custom assay development services. The company was incorporated in 2008 and is based in Liverpool, the United Kingdom.
